Clinical trials in Stockholm – page 29

745 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Stockholm at a glance

745

clinical trials

Research sites8

Quick filters

745 trials in Stockholm

Open in trial search

End stage renal disease+1

Not yet recruiting

Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

Registered drugNo placebo

Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Heparin Sodium
Sponsor:Aplagon Oy

Contact Research Centre

Cardiovascular disorder+3

Not yet recruiting

Effect of dapagliflozin on cardiovascular events in patients receiving chronic dialysis

Registered drugNo placebo

Effect of dapagliflozin on cardiovascular events in patients receiving chronic dialysis

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Karolinska University Hospital

Contact Research Centre

Pulmonary embolism

Not yet recruiting

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Alteplase
Sponsor:University Of Gothenburg

Contact Research Centre

A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

Not yet recruiting

Registered drugNo placebo

A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:AZD0120
Sponsor:AstraZeneca AB

Contact Research Centre

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Norwegian University Of Science And Technolology

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational

Sweden

Participants:65+ years
Substances:TML-6
Sponsor:Merry Life Biomedical Co. Ltd.

Contact Research Centre

Sedative therapy

Not yet recruiting

Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

Registered drugNo placebo

Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Alfentanil
Sponsor:Karolinska Institutet

Contact Research Centre

Malignant melanoma stage IV+1

Not yet recruiting

Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

Registered drugNo placebo

Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Momelotinib
Sponsor:Karolinska University Hospital

Contact Research Centre

Adrenogenital syndrome

Not yet recruiting

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo

Sweden

Participants:18–64 years
Substances:Crinecerfont
Sponsor:Neurocrine Biosciences Inc.

Contact Research Centre

Abortion induced

Not yet recruiting

Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

Registered drug

Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

Registered drug

Sweden

Participants:18–64 years
Substances:Mannitol
Sponsor:Karolinska Institutet

Contact Research Centre

Colorectal cancer

Not yet recruiting

Conversion intraperitoneal chemotherapy with oxaliplatin plus drug combination in colorectal cancer with peritoneal metastases unsuitable for upfront surgery or HIPEC

Registered drugNo placebo

Conversion intraperitoneal chemotherapy with oxaliplatin plus drug combination in colorectal cancer with peritoneal metastases unsuitable for upfront surgery or HIPEC

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:Uppsala University Hospital

Contact Research Centre

Palliative care

Not yet recruiting

Morphine Hydrochloride for Resting Breathlessness in Adults with Serious Chronic Life‑Limiting Disease Receiving Palliative Care

Registered drug

Morphine Hydrochloride for Resting Breathlessness in Adults with Serious Chronic Life‑Limiting Disease Receiving Palliative Care

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Region Skane

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Stockholm

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.

Prostate Cancer Therapies
Breast Cancer Treatments
Colorectal Cancer Studies

Innovative research comparing various treatment protocols and investigating survival outcomes.

02 Infectious Diseases

Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.

Vaccine Development
Viral Disease Prevention
Immunization Studies

Focus on prevention and immune response in various age groups.

03 Cardiovascular Health

Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.

Cardiac Arrest Management
Heart Failure Prevention
Cardiomyopathy Treatment

Emphasis on improving patient outcomes and testing novel drug combinations.

04 Neurological Disorders

Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.

Disease Modification
Symptom Management
Treatment Efficacy

Studies evaluating both novel and existing therapeutic approaches.

05 Metabolic Conditions

Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.

Weight Management
Diabetes Control
Metabolic Health

Focus on lifestyle interventions combined with pharmaceutical approaches.

Back to Sweden All countries